The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography

IF 3.2 3区 医学 Q1 CLINICAL NEUROLOGY Journal of the Neurological Sciences Pub Date : 2006-10-25 Epub Date: 2006-06-15 DOI:10.1016/j.jns.2006.05.004
V. Dhawan , S. Dhoat , A.J. Williams , A. DiMarco , S. Pal , A. Forbes , A. Tobías , P. Martinez-Martin , K. Ray Chaudhuri
{"title":"The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography","authors":"V. Dhawan ,&nbsp;S. Dhoat ,&nbsp;A.J. Williams ,&nbsp;A. DiMarco ,&nbsp;S. Pal ,&nbsp;A. Forbes ,&nbsp;A. Tobías ,&nbsp;P. Martinez-Martin ,&nbsp;K. Ray Chaudhuri","doi":"10.1016/j.jns.2006.05.004","DOIUrl":null,"url":null,"abstract":"<div><p><span>In this study we have explored the nature and range of sleep dysfunction that occurs in untreated Parkinson's disease (PD) comparing data obtained from the use of the Parkinson's disease sleep scale (PDSS) in an untreated PD patient group compared to advanced PD and healthy controls. 25 untreated (drug-naive, DNPD) PD patients (mean age 66.9 years, range 53–80, 18 males) completed the validated Parkinson's disease sleep scale (PDSS), mean duration of PD was 2.1 years (1–10, up to 4 years in all except one patient with tremulous PD reporting tremor duration of 10 years) and mean Hoehn and Yahr score 1.9 (1–3). Data were compared to 34 advanced PD (mean age 70.2 years, range 51–88, 23 male), mean duration of PD 11 years (range 4–22), mean Hoehn and Yahr score 3.4 (3–5) and PDSS data obtained from 131 healthy controls (mean age 66.6 years, range 50–93, 56 males). Total PDSS scores and PDSS sub-items, except PDSS item 2, were highly significantly different (</span><em>p</em> <!-->&lt;<!--> <!-->0.001) between DNPD, advanced PD and controls. Controls reported higher mean PDSS scores than both groups of patients, and advanced cases reported lower (mean<!--> <!-->±<!--> <!-->S.D.) PDSS scores (86.95<!--> <!-->±<!--> <!-->20.78) than drug-naive (105.72<!--> <!-->±<!--> <!-->21.5) (<em>p</em> <!-->&lt;<!--> <span>0.001). Logistic regression analysis showed that items PDSS8 (nocturia), PDSS11 (cramps), PDSS12 (dystonia), PDSS13 (tremor), and PDSS15 (daytime somnolence) were significantly impaired in DNPD compared to controls while PDSS7 (nighttime hallucinations) additionally separated advanced PD from DNPD. In a subgroup of 11 advanced PD cases (mean age 62 years, range</span> <!-->=<!--> <!-->49–84 years, mean Hoehn and Yahr score 2.5, range<!--> <!-->=<!--> <span><span>1–3) with high Epworth Sleepiness Scale (ESS) scores (mean 14.5), low item 15 PDSS score (mean 4.7) and complaints of severe daytime sleepiness, underwent detailed overnight </span>polysomnography (PSG) studies, all showing abnormal sleep patterns.</span></p><p><span>We conclude that nocturia<span>, nighttime cramps, dystonia, tremor and daytime somnolence seem to be the important nocturnal disabilities in DNPD and some of these symptoms may be reminiscent of “off” period related symptoms even though patients are untreated. Furthermore, polysomnography in “sleepy” PD patients may help diagnose unrecognised conditions such as </span></span>periodic limb movement<span> of sleep (PLMS), obstructive sleep apnoea<span> (OSA) and REM Sleep Behaviour Disorder.</span></span></p></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"248 1","pages":"Pages 158-162"},"PeriodicalIF":3.2000,"publicationDate":"2006-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jns.2006.05.004","citationCount":"99","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022510X06002048","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2006/6/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 99

Abstract

In this study we have explored the nature and range of sleep dysfunction that occurs in untreated Parkinson's disease (PD) comparing data obtained from the use of the Parkinson's disease sleep scale (PDSS) in an untreated PD patient group compared to advanced PD and healthy controls. 25 untreated (drug-naive, DNPD) PD patients (mean age 66.9 years, range 53–80, 18 males) completed the validated Parkinson's disease sleep scale (PDSS), mean duration of PD was 2.1 years (1–10, up to 4 years in all except one patient with tremulous PD reporting tremor duration of 10 years) and mean Hoehn and Yahr score 1.9 (1–3). Data were compared to 34 advanced PD (mean age 70.2 years, range 51–88, 23 male), mean duration of PD 11 years (range 4–22), mean Hoehn and Yahr score 3.4 (3–5) and PDSS data obtained from 131 healthy controls (mean age 66.6 years, range 50–93, 56 males). Total PDSS scores and PDSS sub-items, except PDSS item 2, were highly significantly different (p < 0.001) between DNPD, advanced PD and controls. Controls reported higher mean PDSS scores than both groups of patients, and advanced cases reported lower (mean ± S.D.) PDSS scores (86.95 ± 20.78) than drug-naive (105.72 ± 21.5) (p < 0.001). Logistic regression analysis showed that items PDSS8 (nocturia), PDSS11 (cramps), PDSS12 (dystonia), PDSS13 (tremor), and PDSS15 (daytime somnolence) were significantly impaired in DNPD compared to controls while PDSS7 (nighttime hallucinations) additionally separated advanced PD from DNPD. In a subgroup of 11 advanced PD cases (mean age 62 years, range = 49–84 years, mean Hoehn and Yahr score 2.5, range = 1–3) with high Epworth Sleepiness Scale (ESS) scores (mean 14.5), low item 15 PDSS score (mean 4.7) and complaints of severe daytime sleepiness, underwent detailed overnight polysomnography (PSG) studies, all showing abnormal sleep patterns.

We conclude that nocturia, nighttime cramps, dystonia, tremor and daytime somnolence seem to be the important nocturnal disabilities in DNPD and some of these symptoms may be reminiscent of “off” period related symptoms even though patients are untreated. Furthermore, polysomnography in “sleepy” PD patients may help diagnose unrecognised conditions such as periodic limb movement of sleep (PLMS), obstructive sleep apnoea (OSA) and REM Sleep Behaviour Disorder.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
未经治疗的帕金森病(PD)睡眠功能障碍的范围和性质。使用帕金森病睡眠量表和选择性多导睡眠图的对照临床研究
在这项研究中,我们探索了未经治疗的帕金森病(PD)中发生的睡眠功能障碍的性质和范围,并将未经治疗的PD患者组与晚期PD和健康对照者使用帕金森病睡眠量表(PDSS)获得的数据进行了比较。25名未经治疗(未用药,DNPD)的PD患者(平均年龄66.9岁,53-80岁,18名男性)完成了验证的帕金森病睡眠量表(PDSS), PD的平均持续时间为2.1年(1-10年,除1名震颤性PD患者报告震颤持续时间为10年外,所有患者均长达4年),平均Hoehn和Yahr评分为1.9(1-3)。数据比较了34例晚期PD(平均年龄70.2岁,范围51-88岁,男性23例),PD平均病程11年(范围4-22年),平均Hoehn和Yahr评分3.4(3-5)和131例健康对照(平均年龄66.6岁,范围50-93岁,男性56例)的PDSS数据。PDSS总分与PDSS分项除PDSS分项2外,其余分项差异均极显著(p <晚期PD和对照组之间的差异为0.001)。对照组患者的平均PDSS评分高于两组患者,晚期患者的平均PDSS评分低于两组患者(平均±sd)。PDSS评分(86.95±20.78)高于未用药(105.72±21.5)(p <0.001)。Logistic回归分析显示,与对照组相比,PDSS8(夜尿症)、PDSS11(痉挛)、PDSS12(肌痉挛)、PDSS13(震颤)和PDSS15(日间嗜睡)项在DNPD中显著受损,而PDSS7(夜间幻觉)进一步将晚期PD与DNPD区分开。在11例晚期PD患者(平均年龄62岁,范围49-84岁,Hoehn和Yahr平均评分2.5,范围1-3)的亚组中,Epworth嗜睡量表(ESS)得分高(平均14.5),PDSS第15项得分低(平均4.7),并抱怨白天严重嗜睡,进行了详细的夜间多导睡眠图(PSG)研究,均显示异常睡眠模式。我们的结论是夜尿、夜间痉挛、肌张力障碍、震颤和白天嗜睡似乎是DNPD中重要的夜间残疾,即使患者未经治疗,其中一些症状也可能使人联想到“非”期相关症状。此外,“困倦”PD患者的多导睡眠图可能有助于诊断未被识别的疾病,如周期性睡眠肢体运动(PLMS)、阻塞性睡眠呼吸暂停(OSA)和快速眼动睡眠行为障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of the Neurological Sciences
Journal of the Neurological Sciences 医学-临床神经学
CiteScore
7.60
自引率
2.30%
发文量
313
审稿时长
22 days
期刊介绍: The Journal of the Neurological Sciences provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. JNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials). JNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism.
期刊最新文献
Comment on “efficacy of glucagon-like Peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis” Association between periventricular white matter hyperintensities around the anterior horn and CSF tap test responsiveness in idiopathic normal pressure hydrocephalus Evidence for compromised function of the glymphatic system in pediatric acquired demyelinating disorders Response to “Comment on ‘efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis’” The effect of end-tidal carbon dioxide levels on dynamic cerebral autoregulation and clinical outcome in acute ischemic stroke: An INFOMATAS study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1